Paracetamol Pharmacology and Toxicity
Paracetamol Pharmacology and Toxicity
Paracetamol Pharmacology and Toxicity
and Toxicity
Pharmacology
❖ Type : NSAIDS - Analgesic-antipyretics with poor anti-in ammatory action
❖ Action: It raises pain threshold, but has weak peripheral anti-in ammatory
component. It is a poor inhibitor of PG synthesis in peripheral tissues, but more
active on COX in the brain. The ability of paracetamol to inhibit COX-3 could also
account for its analgesic- antipyretic action.
❖ Pharmacokinetics: Absorption: is well absorbed orally. Distribution: Equally in the
body. Metabolism: Conjugation with glucuronic acid and sulfate in Liver.
Excretion: By kidney. Plasma t1⁄2 is 2–3 hours. Effects after an oral dose last for 3–5
hours.
❖ Adverse effects: Nausea and rashes occur occasionally, leukopenia is rare.
fl
fl
Uses
❖ Analgesic for headache, mild migraine, musculoskeletal pain, dysmenorrhoea,
etc.
❖ It is one of the best drugs to be used as antipyretic, especially in children (no
risk of Reye’s syndrome).
❖ Dose to dose it is equally ef cacious as aspirin for non-in ammatory conditions.
❖ Dose: 325–650 mg (children 10–15 mg/kg) 3–5 times a day.
❖ Paracetamol is not recommended in premature infants (< 2 kg) for fear of
hepatotoxicity.
fi
fl
Toxicity
❖ The toxic dose is usually >200 mg/kg in children below 12-yr-old. Hepatic damage after
paracetamol overdose usually begins at >150 mg/ kg.
❖ Mechanism of toxicity: When a very large dose of paracetamol is taken, glucuronidation capacity
is saturated, hepatic glutathione is depleted and the metabolite (N-acetyl-p-benzoquinoneimine)
binds covalently to proteins in liver cells (and renal tubules) causing necrosis.
1. Stage I (12-24 hr): Nausea, vomiting and cold sweats
2. Stage II (24-48 hr): Clinical recovery with biochemical evidence of hepatorenal injury
3. Stage III (48-96 hr): Peak hepatotoxicity
4. Stage IV (7-8 days): Recovery is heralded by return of consciousness and improvement in the
hepatic function tests. Histological recovery may take up to 3 months.
5. Death may occur within 2-7 days of ingestion.
References:
❖ Essential Paediatrics Edition 8 by OP GHAI
❖ Essentials of Medical Pharmacology Seventh Edition by KD TRIPATHI
Thankyou